Conference abstract · 11 Jul 2016
Conference abstractPublished 19 Oct 2016
Biosimilars regulations: Updates from Canada
Quintiles, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biosimilars is still a relatively new and rapidly developing area of biologics; as such there are ongoing changes in regulatory requirements for biosimilars in different countries across the globe. Recent changes in regulatory requirements in USA and EU have definitely attracted much attention and sparked many comments and discussions. In light of changes in these two jurisdictions, the regulatory landscape in Canada is somewhat overlooked. However, a few interesting and exciting changes in regulatory requirements for Subsequent Entry Biologics (SEBs) have occured in Canada in the last year. Examples include the revision of the guidance document âÂ?Â?Information and Submission Requirements for Subsequent Entry Biologics (SEBs)âÂ? and the SEB Scientific Advice Meeting Pilot project. This presentation will address the following questions: Are there more differences than similarities between Health Canada, FDA and EMA regulatory requirements, and what is the future perspective?
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Oct 2015
Biologics & Biosimilars: The Current Litigation Landscape in Canada
Conference abstract
Biosimilars? pricing policies in Canada: A new challenge to provincial governments
Conference abstract · 4 Apr 2024
Regulatory updates on Biosimilars
Conference abstract · 3 Oct 2023
Biosimilars in LATAM: A Regulatory Update and Review
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Oxana Iliach”

